1344 related articles for article (PubMed ID: 26672090)
41. Prevalence and correlates of microalbuminuria in Yemeni children with sickle cell disease.
Al-Musawa FE; Al-Saqladi AM
Saudi J Kidney Dis Transpl; 2019; 30(4):832-842. PubMed ID: 31464240
[TBL] [Abstract][Full Text] [Related]
42. Exploring putative genetic determinants of inter-individual phenotypic heterogeneity in sickle cell disease: A cross-sectional Jamaican cohort-based study.
Marshall K; Howell S; Badaloo A; Reid M; McFarlane-Anderson N; McKenzie C
Blood Cells Mol Dis; 2018 Nov; 73():1-8. PubMed ID: 30120022
[TBL] [Abstract][Full Text] [Related]
43. Plasma levels of some coagulation parameters in steady state HBSC disease patients.
Ajuwon MD; Olayemi E; Benneh AA
Pan Afr Med J; 2014; 19():289. PubMed ID: 25870744
[TBL] [Abstract][Full Text] [Related]
44. Paediatric sickle cell disease: pulmonary hypertension but normal vascular resistance.
Chaudry RA; Cikes M; Karu T; Hutchinson C; Ball S; Sutherland G; Rosenthal M; Bush A; Crowley S
Arch Dis Child; 2011 Feb; 96(2):131-6. PubMed ID: 21030373
[TBL] [Abstract][Full Text] [Related]
45. Knowledge insufficient: the management of haemoglobin SC disease.
Pecker LH; Schaefer BA; Luchtman-Jones L
Br J Haematol; 2017 Feb; 176(4):515-526. PubMed ID: 27982424
[TBL] [Abstract][Full Text] [Related]
46. Serum lactate dehydrogenase activity as a biomarker in children with sickle cell disease.
O'Driscoll S; Height SE; Dick MC; Rees DC
Br J Haematol; 2008 Jan; 140(2):206-9. PubMed ID: 18028483
[TBL] [Abstract][Full Text] [Related]
47. Sickle cell disease: A distinction of two most frequent genotypes (HbSS and HbSC).
da Guarda CC; Yahouédéhou SCMA; Santiago RP; Neres JSDS; Fernandes CFL; Aleluia MM; Figueiredo CVB; Fiuza LM; Carvalho SP; Oliveira RM; Fonseca CA; Ndidi US; Nascimento VML; Rocha LC; Goncalves MS
PLoS One; 2020; 15(1):e0228399. PubMed ID: 31995624
[TBL] [Abstract][Full Text] [Related]
48. Association between hemolysis and albuminuria in adults with sickle cell anemia.
Day TG; Drasar ER; Fulford T; Sharpe CC; Thein SL
Haematologica; 2012 Feb; 97(2):201-5. PubMed ID: 21993677
[TBL] [Abstract][Full Text] [Related]
49. Retinal thickness measurements in sickle cell patients with HbSS and HbSC genotype.
Lim WS; Magan T; Mahroo OA; Hysi PG; Helou J; Mohamed MD
Can J Ophthalmol; 2018 Aug; 53(4):420-424. PubMed ID: 30119799
[TBL] [Abstract][Full Text] [Related]
50. Low nitric oxide level is implicated in sickle cell disease and its complications in Ghana.
Antwi-Boasiako C; Campbell AD
Vasc Health Risk Manag; 2018; 14():199-204. PubMed ID: 30233199
[TBL] [Abstract][Full Text] [Related]
51. The 6-min walk test: an independent correlate of elevated tricuspid regurgitant jet velocity in children and young adult sickle cell patients.
Agha H; El Tagui M; El Ghamrawy M; Abdel Hady M
Ann Hematol; 2014 Jul; 93(7):1131-8. PubMed ID: 24562420
[TBL] [Abstract][Full Text] [Related]
52. Large and medium-sized pulmonary artery obstruction does not play a role of primary importance in the etiology of sickle-cell disease-associated pulmonary hypertension.
van Beers EJ; van Eck-Smit BL; Mac Gillavry MR; van Tuijn CF; van Esser JW; Brandjes DP; Kappers-Klunne MC; Duits AJ; Biemond BJ; Schnog JJ;
Chest; 2008 Mar; 133(3):646-52. PubMed ID: 18198257
[TBL] [Abstract][Full Text] [Related]
53. Comparative studies of live neonates in maternal sickle cell haemoglobinopathy in Ghana.
Addai FK; Wilson JB; Quashie FJ
Trop Geogr Med; 1992 Oct; 44(4):312-6. PubMed ID: 1295139
[TBL] [Abstract][Full Text] [Related]
54. [Screening for nephropathy in major sickle cell syndromes in patients monitored at the National Reference Center for Sickle Cell Disease in Niamey, Niger].
Garba M; Moussa Tondi ZM; Diongoule H; Aboubacar S; Ide A; Biyao-Nelson NR; Soumaila I; Alido S
Nephrol Ther; 2018 Nov; 14(6):462-466. PubMed ID: 29311011
[TBL] [Abstract][Full Text] [Related]
55. Unusually High Prevalence of Stroke and Cerebral Vasculopathy in Hemoglobin SC Disease: A Retrospective Single Institution Study.
Sathi BK; Yoshida Y; Weaver MR; Nolan LS; Gruner B; Balasa V; Altes T; Leiva-Salinas C
Acta Haematol; 2022; 145(2):160-169. PubMed ID: 34749363
[TBL] [Abstract][Full Text] [Related]
56. Degree of anemia, indirect markers of hemolysis, and vascular complications of sickle cell disease in Africa.
Dubert M; Elion J; Tolo A; Diallo DA; Diop S; Diagne I; Sanogo I; Belinga S; Guifo O; Wamba G; Ngo Sack F; Boidy K; Kamara I; Traore Y; Diakite CO; Gbonon V; Faye BF; Seck M; Deme Ly I; Chelo D; N'Guetta R; Diop IB; Gaye B; Jouven X; Ranque B
Blood; 2017 Nov; 130(20):2215-2223. PubMed ID: 28931524
[TBL] [Abstract][Full Text] [Related]
57. Serum apelin as a novel non-invasive marker for subclinical cardiopulmonary complications in children and adolescents with sickle cell disease.
Elbarbary NS; Ismail EA; Roushdy A; Fahmy E
Blood Cells Mol Dis; 2016 Mar; 57():1-7. PubMed ID: 26852648
[TBL] [Abstract][Full Text] [Related]
58. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.
Gladwin MT; Sachdev V; Jison ML; Shizukuda Y; Plehn JF; Minter K; Brown B; Coles WA; Nichols JS; Ernst I; Hunter LA; Blackwelder WC; Schechter AN; Rodgers GP; Castro O; Ognibene FP
N Engl J Med; 2004 Feb; 350(9):886-95. PubMed ID: 14985486
[TBL] [Abstract][Full Text] [Related]
59. Platelet P-selectin and platelet mass, volume and component in sickle cell disease: relationship to genotype.
Mohan JS; Lip GY; Bareford D; Blann AD
Thromb Res; 2006; 117(6):623-9. PubMed ID: 16051315
[TBL] [Abstract][Full Text] [Related]
60. Prevalence, treatment, and outcomes of renal conditions in pediatric sickle cell disease.
Stallworth JR; Tripathi A; Jerrell JM
South Med J; 2011 Nov; 104(11):752-6. PubMed ID: 22024785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
